Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tremelimumab”

216 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 216 results

Testing effectiveness (Phase 2)Looking for participantsNCT05844046
What this trial is testing

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Enrico De Toni 83
Early research (Phase 1)Study completedNCT03089645
What this trial is testing

MEDI5083 Alone and in Combination With Durvalumab, Tremelimumab, and/or Docetaxel.

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 39
Testing effectiveness (Phase 2)Looking for participantsNCT05440864
What this trial is testing

Durvalumab and Tremelimumab in Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto 28
Testing effectiveness (Phase 2)Study completedNCT02821754
What this trial is testing

A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)

Who this might be right for
Biliary Tract NeoplasmsLiver CancerHepatocellular Carcinoma+2 more
National Cancer Institute (NCI) 54
Very early researchStudy completedNCT02626130
What this trial is testing

Tremelimumab With or Without Cryoablation in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CancerStage IV Renal Cell Cancer AJCC v7
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT02571725
What this trial is testing

PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Neoplasms
New Mexico Cancer Research Alliance 50
Testing effectiveness (Phase 2)Looking for participantsNCT06911255
What this trial is testing

Safety and Efficacy of Tremelimumab+Durvalumab(MEDI4736)+TACE in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)Unresectable Hepatocellular Carcinoma
Yoon Jun Kim 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07226063
What this trial is testing

Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
Amit Mahipal 16
Testing effectiveness (Phase 2)Study completedNCT03026062
What this trial is testing

Durvalumab and Tremelimumab in Treating Participants With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more
M.D. Anderson Cancer Center 100
Early research (Phase 1)WithdrawnNCT00880854
What this trial is testing

Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer

Who this might be right for
Bladder Cancer
University of Wisconsin, Madison
Early research (Phase 1)Ended earlyNCT03277482
What this trial is testing

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Who this might be right for
Recurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more
Dana-Farber Cancer Institute 16
Testing effectiveness (Phase 2)WithdrawnNCT05120622
What this trial is testing

Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh-Risk CancerTremelimumab+2 more
University of British Columbia
Testing effectiveness (Phase 2)Active Not RecruitingNCT02519348
What this trial is testing

Durvalumab or Tremelimumab Monotherapy, or Durvalumab in Combination With Tremelimumab or Bevacizumab in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
MedImmune LLC 433
Testing effectiveness (Phase 2)Study completedNCT02319044
What this trial is testing

Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck
AstraZeneca 267
Testing effectiveness (Phase 2)Active Not RecruitingNCT03601455
What this trial is testing

Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer

Who this might be right for
Bladder Urothelial CarcinomaStage IV Bladder Cancer AJCC v8Stage IVA Bladder Cancer AJCC v8+1 more
Jonsson Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT04522544
What this trial is testing

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectableHCC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 55
Testing effectiveness (Phase 2)Study completedNCT03122509
What this trial is testing

A Clinical Trial of Durvalumab and Tremelimumab, Administered With Radiation Therapy or Ablation in Patients With Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Looking for participantsNCT06680739
What this trial is testing

Single cEll pRofiling PErsistaNce To ImmuNothErapy

Who this might be right for
Colorectal CancerEndometrial Cancer
Vall d'Hebron Institute of Oncology 60
Testing effectiveness (Phase 2)Looking for participantsNCT04499053
What this trial is testing

Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Georgetown University 18
Large-scale testing (Phase 3)Study completedNCT02551159
What this trial is testing

Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 823
Next Page